Clinical trial
Sleep Disorders and Gastroesophageal Reflux Disease (GERD)
NCT00287391 · University of North Carolina, Other · Completed
Key facts
| NCT number | NCT00287391 |
|---|---|
| Title | Sleep Disorders and Gastroesophageal Reflux Disease (GERD) |
| Official title | The Impact of Gastroesophageal Reflux Disease in Sleep Disorders: A Pilot Investigation of Rabeprazole, 20 mg Twice Daily for the Relief of GERD-Related Insomnia. |
| Lead sponsor | University of North Carolina, Other |
| Collaborators | Janssen Pharmaceutica N.V., Belgium Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Insomnia, GERD |
| Intervention type | Drug |
| Interventions | Rabeprazole |
| Enrollment | 20 |
| Start date | Sep 1, 2004 |
| Completion | Dec 1, 2006 |
| First posted | Feb 6, 2006 |
| Last update posted | Apr 27, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: